You are here

Singer_indefenseofliberty_naxolone

Submitted by Anonymous (not verified) on Thu, 04/19/2018 - 10:25am
Headline: 
Why Doesn't the Surgeon General Seek FDA Reclassification of Naloxone to OTC?
Publication Date: 
Wednesday, April 18, 2018
Type: 
article
Format: 
Newspaper (Online)
Nature of Mention: 
authored
Custom Description: 
Cato@Liberty post authored by Jeffrey A. Singer on deregulating naxolone re-printed at In Defense of Liberty (Goldwater Institute): "Why Doesn't the Surgeon General Seek FDA Reclassification of Naloxone to OTC?"